Page 22 - 2018_04

evidência científica crescente sustenta a HIO como uma entidade clínica real3,20.
A HIO quando não diagnosticada pode ter consequências prejudiciais para o doente e a sua abordagem carece de um acompanhamen- to especializado.
Conflito de interesses
Nada a declarar.
Bibliografia
1. Angst MS, Clark JD. Opioid-induced hyperalgesia: a quantitative systematic review. Anesthesiology. 2006;104(3):570-87.
2. Merskey H, Bogduk N. Part III: Pain Terms, A Current List with Definitions and Notes on Usage Classification of Chronic Pain, Sec- ond Edition, IASP Task Force on Taxonomy. Seattle: IASP Press. 1994:209-14.
3. Yi P, Pryzbylkowski P. Opioid Induced Hyperalgesia. Pain Med. 2015;16(1):S32-6.
4. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24(6):479-96.
5. Leal PC, Clivatti J, Garcia JBS, Sakata RK. Hiperalgesia induzida por opioides (HIO). Revista Brasileira de Anestesiologia. 2010;60(6): 643-7.
6. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002;100(3):213-7.
7. Silverman S. Opioid induced hyperalgesia: Clinical implications for the pain ractitioner. Pain Physician. 2009;12(3):679-84.
8. DuPen A, Shen D, Ersek M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Mange Nurs. 2007;8(3):113-21.
9. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged mor- phine exposure. Biopolymers. 2005;80(2-3):319-24.
10. Simonnet G, Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport. 2003;14(1):1-7.
11.
12.
13.
14.
15. 16.
17.
18. 19.
20. 21.
22.
23.
R. Inácio, J. de
Jesus: Hiperalgesia Induzida pelos Opioides: Mito ou Realidade?
Vanderah TW, Ossipov MH, Lai J, Malan TP Jr., Porreca F. Mecha- nisms of opioid-induced pain and antinociceptive tolerance: de- scending facilitation and spinal dynorphin. Pain. 2001;92(1-2):5-9. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000;93(2):409-17.
Hood D, Curry R, Eisenach, JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-Induced hiper- algesia. Anesth Analg. 2003;97(3):810-5.
Woodward OB, Naraen S, Naraen A. Opioid-induced myoclonus and hyperalgesia following a short course of low-dose oral morphine. British Journal of Pain. 2017;11(1):32-5.
Koppert W, Schmelz M. The impact of opioid-induced hyperalgesia for postoperative pain. Best Pract Res Clin Anaesthesiol. 2007;21(1):65-83. Schmidt S, Bethge C, Förster MH, Schäfer M. Enhanced postopera- tive sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin J Pain. 2007;23(7):605-11.
Eisenberg E, Suzan E, Pud D. Opioid-induced hyperalgesia (OIH): A real clinical problem or just an experimental phenomenon? J Pain Symptom Manage. 2015;49(3):632-6.
Mercandante S, Arcuri E. Hyperalgesia and opioid switching. Am J Hospice Palliative Med. 2005;22(4):291-4.
DeKock MF, Lavand’homme PM. The clinical role of NMDA receptor antagonist for the treatment of postoperative pain. Best Pract Res Clin Anaesthesiol. 2007;21(1):85-98.
Bannister K. Opioid-induced hyperalgesia: Where are we now? Curr Opin Support Palliat Care. 2015;9(2):116-21.
Tsai RY, Tai YH, Tzeng JI, Cherng CH, Yeh CC, Wong CS. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of l-opioid receptors from Gs-protein to coupling to Gi-protein. Neuroscience. 2009;164(2):435-43.
Singler B, Tröster A, Manering N, Schüttler J, Koppert W. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anes- th Analg. 2007;104(6):1397-403.
Colvin LA, Fallon MT. Opioid-induced hyperalgesia: a clinical chal- lenge. Br J Anaesth. 2010;104(2):125-7.
21
DOR